Our Services
Medical Information
Helpful Resources
Published on: 9/22/2026
Ketorolac (Toradol) is a potent nonsteroidal anti-inflammatory drug (NSAID) prescribed for short-term relief of moderate to severe acute pain, including pain after surgery or injury, kidney stone pain, and severe migraines, and it is not meant for mild or long-term chronic pain. Because of risks such as stomach bleeding, ulcers, kidney injury, and heart or stroke events, total treatment across all forms (injection, IV, oral tablets, or nasal spray) should generally not exceed 5 days combined. Dosing limits vary by age, kidney function, weight, and route, and there are important cautions, contraindications, and drug interactions to consider, which are explained below. If your pain persists past that short window, that is often a signal the underlying cause needs to be identified rather than simply medicated longer.
Understanding what is actually driving your pain helps you avoid unnecessary medication risks and get to the right treatment faster, and you can start in just a few minutes by taking a free, instant, online symptom check to review your symptoms and clarify your next steps.
Last reviewed for medical accuracy: 09/22/2026
Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) commonly prescribed for short-term relief of moderate to severe pain. It’s known for its effectiveness in reducing inflammation and pain without the need for opioid medications. Below, you’ll find a clear overview of ketorolac’s uses, how it works, proper duration of use, potential side effects, precautions, and tips to help you use it safely.
Ketorolac is primarily used for short-term management of pain when non-NSAID therapies are insufficient. Typical indications include:
Because of its potency, ketorolac is not intended for routine, long-term pain control. It’s often reserved for situations where immediate, strong pain relief is needed, and other NSAIDs or non-opioid painkillers are inadequate.
Ketorolac blocks enzymes called cyclooxygenases (COX-1 and COX-2), which are involved in the production of prostaglandins. Prostaglandins contribute to inflammation, pain, and fever. By reducing prostaglandin levels, ketorolac:
Its rapid onset makes it useful in emergency or postoperative settings. Ketorolac does not have the sedative or addictive properties of opioids, but it must be used carefully to avoid serious side effects.
Ketorolac is available in several formulations:
Typical dosing guidelines for adults:
Always follow your healthcare provider’s instructions. Doses may be adjusted based on age, kidney function, and overall health.
Because of risks to the stomach, kidneys, and bleeding, ketorolac has strict limits on duration of use:
Continuing treatment beyond these limits significantly increases the risk of serious complications, including gastrointestinal bleeding, kidney injury, and cardiovascular events.
Most people tolerate ketorolac for short courses, but you may experience:
These effects often improve as your body adjusts. Taking ketorolac with food or a glass of milk may help reduce stomach discomfort.
While ketorolac is effective for acute pain, it carries black-box warnings for serious adverse events. Be aware of:
Avoid ketorolac if you have:
Ketorolac may interact with:
Always tell your healthcare provider about all prescription and over-the-counter medicines you’re taking.
If you experience any of the following, stop ketorolac and seek immediate medical attention:
For any other concerns or less urgent symptoms, it’s wise to discuss them with your healthcare provider. You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Ketorolac is a powerful NSAID reserved for short-term relief of moderate to severe pain, especially after surgery or in acute injury. Its strong effect comes with a higher risk of side effects if used too long or inappropriately. Key points to remember:
Always follow your doctor’s instructions and report any worrisome symptoms right away. If you suspect a serious reaction or life-threatening condition, stop taking ketorolac and speak to a doctor immediately.
(References)
* Miranda HF, Sierralta F, Pinardi G. Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice. Anesth Analg. 1993 Oct;77(4):750-3. doi: 10.1213/00000539-199310000-00016. PMID: 8214659.
* Amrish C, Kumar SP. Transdermal delivery of ketorolac. Yakugaku Zasshi. 2009 Mar;129(3):373-9. doi: 10.1248/yakushi.129.373. PMID: 19252396.
* Kotagal M, Hakkarainen TW, Simianu VV, Beck SJ, Alfonso-Cristancho R, Flum DR. Ketorolac Use and Postoperative Complications in Gastrointestinal Surgery. Ann Surg. 2016 Jan;263(1):71-5. doi: 10.1097/SLA.0000000000001260. PMID: 26106831; PMCID: PMC4684464.
* Hawkins AT, McEvoy MD, Wanderer JP, Ford MM, Hopkins MB, Muldoon RL, Martin BJ, King AB, Geiger TM. Ketorolac Use and Anastomotic Leak in Elective Colorectal Surgery: A Detailed Analysis. Dis Colon Rectum. 2018 Dec;61(12):1426-1434. doi: 10.1097/DCR.0000000000001244. PMID: 30371548.
* Liu Z, Cheng S, Fu G, Ji F, Wang C, Cao M. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer. Life Sci. 2020 Jun 15;251:117604. doi: 10.1016/j.lfs.2020.117604. Epub 2020 Mar 31. PMID: 32243929.
* Corsini EM, Hofstetter WL, MD Anderson Esophageal Cancer Working Group. Ketorolac use and anastomotic leak in patients with esophageal cancer. J Thorac Cardiovasc Surg. 2021 Feb;161(2):448-454. doi: 10.1016/j.jtcvs.2020.02.133. Epub 2020 Mar 21. PMID: 32340809.
* Cunningham D, Lewis B. The Effect of Perioperative Ketorolac Administration on Opioid Use After Hip Arthroscopy. Orthopedics. 2021 May-Jun;44(3):e417-e421. doi: 10.3928/01477447-20210414-16. Epub 2021 May 1. PMID: 34039207.
* Ganesan V, Steinberg RL, Trivedi H, Sorokin I, Johnson BA, Gahan JC. Scheduled intravenous ketorolac is safe and reduces narcotic use after robotic-assisted simple prostatectomy. J Robot Surg. 2024 Oct 3;18(1):358. doi: 10.1007/s11701-024-02068-5. Epub 2024 Oct 3. PMID: 39361167.
* Kumar P, Kinger S, Dubey AR, Jagtap YA, Choudhary A, Karmakar S, Lal G, Kumar A, Bhattacharyya S, Poluri KM, Mishra A. Ketorolac disturbs proteasome functions and induces mitochondrial abnormality-associated apoptosis. IUBMB Life. 2025 Jan;77(1):e2937. doi: 10.1002/iub.2937. PMID: 39723629.
* Ogilvie D, Ogilvie B, Mysore A, Joshi T, Drzala M, Kupershtein I, Reiter M, Hullinger H. Postoperative Ketorolac Administration and Pseudoarthrosis Following Lumbar Spinal Fusion: A Matched Cohort Study. Spine (Phila Pa 1976). 2026 Jan 1;51(2):85-91. doi: 10.1097/BRS.0000000000005474. Epub 2025 Aug 19. PMID: 40827608.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.